Geriatric Depression Scale (GDS-15)
15-item self-report screening tool for depression in older adults (>65 years). Avoids somatic items that confound depression screening in the elderly. Short form of original 30-item GDS.
Score interpretation
GDS-15 0-4. No significant depressive symptoms.
→ No immediate action. Reassess at next routine appointment. Ensure social support and activity levels are adequate in older adults.
GDS-15 5-8. Mild depressive symptoms. Follow-up evaluation indicated.
→ Explore psychosocial stressors. Review medications (beta-blockers, corticosteroids, opioids). Lifestyle review (activity, social engagement). Consider talking therapy. Reassess in 4-6 weeks.
GDS-15 9-11. Moderate depression. Treatment recommended.
→ Psychiatry/psychogeriatrics referral. Consider antidepressants (SSRIs preferred in elderly). Assess for cognitive impairment (MMSE/MoCA). Risk assessment for self-harm.
GDS-15 12-15. Severe depressive symptoms.
→ Urgent psychiatry review. Risk assessment — suicidal ideation, self-neglect, capacity. Consider inpatient admission if at risk. Combination of medication and psychotherapy indicated.
Interpretation bands for the GDS-15. Apply clinical judgement and local guidance.
References
- Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1/2):165-173.
- Yesavage JA, et al. Development and validation of a geriatric depression screening scale. J Psychiatr Res. 1982;17(1):37-49.
Related
Curated clinical cross-links plus same-class fallbacks.
- Bisoprolol (Heart Failure in Elderly) · Selective beta-1 blocker
- Sodium Valproate (Epilepsy in Elderly) · Antiepileptic
- Sertraline (Elderly) · SSRI Antidepressant
- Mirtazapine (Elderly) · NaSSA Antidepressant
- Quetiapine (Elderly — Dementia Caution) · Atypical Antipsychotic
- Lorazepam (Elderly — Short-Term Use) · Benzodiazepine
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.